Business Standard

Mixing Covaxin and Covishield safe, gives better immune response: ICMR

The study was conducted on 18 individuals who inadvertently received Covishield as first jab and Covaxin as second in UP at a gap of six weeks

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
Premium

Ruchika Chitravanshi New Delhi
A study by Indian Council of Medical Research has found that mixing the doses of Covishield and Covaxin was not only safe but also elicited a better immune response.

The study was conducted on 18 individuals who inadvertently received Covishield as the first jab and Covaxin as the second in Uttar Pradesh at a gap of six weeks.

The study found that the immunogenicity against Alpha, Beta and Delta variants was superior and the neutralising antibody response of the participants was also significantly higher compared to those who received both doses of the same vaccine.

The preprint study titled Serendipitous

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in